These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 9360524)
1. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes. Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524 [TBL] [Abstract][Full Text] [Related]
2. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446 [TBL] [Abstract][Full Text] [Related]
3. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827 [TBL] [Abstract][Full Text] [Related]
4. Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I. Stowasser M; Taylor WL; Gartside MG; Tunny TJ; Gordon RD J Hypertens; 1997 Dec; 15(12 Pt 2):1729-33. PubMed ID: 9488230 [TBL] [Abstract][Full Text] [Related]
5. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645 [TBL] [Abstract][Full Text] [Related]
8. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810 [TBL] [Abstract][Full Text] [Related]
9. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430 [TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism: learning from the study of familial varieties. Stowasser M; Gordon RD J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications. Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032 [TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619 [TBL] [Abstract][Full Text] [Related]